Rapid Therapeutic Science Laboratories (Rapid Therapeutic Science Laboratories) Retained Earnings : $-10.08 Mil (As of Jun. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Rapid Therapeutic Science Laboratories Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Rapid Therapeutic Science Laboratories's retained earnings for the quarter that ended in Jun. 2023 was $-10.08 Mil.

Rapid Therapeutic Science Laboratories's quarterly retained earnings increased from Dec. 2022 ($-10.32 Mil) to Mar. 2023 ($-10.13 Mil) and increased from Mar. 2023 ($-10.13 Mil) to Jun. 2023 ($-10.08 Mil).

Rapid Therapeutic Science Laboratories's annual retained earnings declined from Mar. 2020 ($-3.60 Mil) to Dec. 2021 ($-8.52 Mil) and declined from Dec. 2021 ($-8.52 Mil) to Dec. 2022 ($-10.32 Mil).

Rapid Therapeutic Science Laboratories Retained Earnings Historical Data

The historical data trend for Rapid Therapeutic Science Laboratories's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rapid Therapeutic Science Laboratories Retained Earnings Chart

Rapid Therapeutic Science Laboratories Annual Data

Trend

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Dec21

Dec22

Retained Earnings

Get a 7-Day Free Trial

-2.63

-2.98

-3.60

-8.52

-10.32

Rapid Therapeutic Science Laboratories Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Retained Earnings	Get a 7-Day Free Trial															-10.14	-10.37	-10.32	-10.13	-10.08

Rapid Therapeutic Science Laboratories Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Rapid Therapeutic Science Laboratories (OTCPK:RTSL) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Rapid Therapeutic Science Laboratories (Rapid Therapeutic Science Laboratories) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rapid Therapeutic Science Laboratories Inc (OTCPK:RTSL) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

5580 Peterson Lane, Suite 120, Dallas, TX, USA, 75201

Website

https://www.rtslco.com

Rapid Therapeutic Science Laboratories Inc is a biotech company specializing in natural-based relief through aerosol delivery of cannabinoids to the systemic bloodstream through the pulmonary route of administration. The company manufactures its own branded metered dose inhalers (MDI) under the nhaler name using proprietary blends of pure cannabinoids such as cannabidiol (CBD) and cannabigerol (CBG). In addition, the company manufactures other aerosol devices for the delivery of cannabinoids other than MDI such as sublingual sprays.

Executives

Henry Anthony Punzi	director	1932 WALNUT PLAZA, CARROLLTON TX 75006
Scott Suggs Justin	director	639 SWORD BRIDGE DR., LEWISVILLE TX 75056
Sean Paul Berrier	10 percent owner	7108 DUFFIELD DR., DALLAS TX 75248
Schmidt Donal Ray Jr.	director, 10 percent owner, officer: President and CEO	5580 PETERSON LANE, SUITE 200, DALLAS TX 75240
Ryan Casey Johnson	director, officer: Chief Operating Officer	2307 CASTLE ROCK RD, CARROLTON TX 75007
Texas Mdi, Inc.	10 percent owner	5580 PETERSON LANE, SUITE 200, DALLAS TX 75240
D Hughes Watler	director, officer: CFO	2323 S. VOSS ROAD, STE. 510-12, HOUSTON TX 77057
Steve Bond	director, officer: CFO	28839 PUJOL ST., #832, TEMECULA CA 92590
Brent Willson	director, officer: CEO and President	5271 CAMINITO EXQUISITO, SAN DIEGO CA 92130